News
Goldman Sachs initiates Teva, Viatris, and Amneal, highlighting branded growth and pipeline strength, but one company's ...
Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price ...
EUROPEAN equities see-sawed on Thursday, ultimately eking out gains after the European Central Bank’s President Christine ...
Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) settled +4.4% in Frankfurt trading Thursday as Goldman Sachs upgraded shares to Buy from ...
Find insight on Bayer and more in the latest Market Talks covering the Health Care sector.
By Purvi Agarwal and Sanchayaita Roy (Reuters) -European shares slipped on Thursday after European Central Bank President ...
Goldman Sachs has moderated its risk-taking since U.S. President Donald Trump's April tariff announcement, and the Wall ...
European stocks traded higher on Thursday ahead of an expected interest-rate cut by the European Central Bank. Investors have fully priced in a 25 basis-point cut, bringing the deposit rate to 2%, and ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
The pan-European STOXX 600 index edged 0.2% higher by 0704 GMT, extending gains from the previous session after Germany’s ...
Simetrik, a financial and accounting services startup, raised $30 million in fresh funding led by a unit of Goldman Sachs Alternatives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results